1 The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
2 Sun Yat-sen University, Guangzhou, China.
Integr Cancer Ther. 2019 Jan-Dec;18:1534735419871108. doi: 10.1177/1534735419871108.
This meta-analysis summarizes the results from recent studies that examined the use of virtual reality (VR)-based interventions on health-related outcomes in patients with cancer, and quantitatively evaluates the efficacy of VR-based interventions. Findings of this meta-analysis can provide direction for future symptom management research. The search terms included a combination of "virtual reality" OR "virtual environment" OR "head-mounted display" with "oncology" OR "cancer." Three databases (Medline, PubMed, and CAJ Full-text Database), one search engine (Google Scholar), and the website of ResearchGate, covering the period from December 2013 to May 15, 2019, and including articles published in both English and Chinese, were searched. Data synthesis used the RevMan 5.3 to generate pooled estimates of effect size. A total of 6 empirical studies met the eligibility criteria. VR-based interventions had statistically significant effects on reducing symptoms of anxiety, depression, pain, and cognitive function, whereas statistically significant benefit was observed for fatigue ( = 2.76, = .006). Most recent studies have primarily examined VR-based interventions for symptom management in the acute stages of cancer care. However, the management of late and long-term side effects is central to cancer survivorship care. There is burgeoning empirical support for further research to evaluate the efficacy of VR-based interventions in cancer rehabilitation.
本荟萃分析总结了近期研究的结果,这些研究考察了虚拟现实 (VR) 干预措施在癌症患者健康相关结局中的应用,并对 VR 干预措施的疗效进行了定量评估。这项荟萃分析的结果可为未来的症状管理研究提供方向。检索词包括“虚拟现实”或“虚拟环境”或“头戴式显示器”与“肿瘤学”或“癌症”的组合。检索了三个数据库(Medline、PubMed 和 CAJ 全文数据库)、一个搜索引擎(Google Scholar)和 ResearchGate 网站,时间范围为 2013 年 12 月至 2019 年 5 月 15 日,包括英文和中文发表的文章。使用 RevMan 5.3 进行数据综合,生成效应大小的汇总估计值。共有 6 项符合纳入标准的实证研究。基于 VR 的干预措施在减轻焦虑、抑郁、疼痛和认知功能症状方面具有统计学意义的效果,而在疲劳方面观察到统计学意义上的益处( = 2.76, =.006)。最近的大多数研究主要考察了 VR 干预措施在癌症治疗急性期的症状管理。然而,癌症生存者护理的核心是管理晚期和长期副作用。有越来越多的实证支持进一步研究评估 VR 干预措施在癌症康复中的疗效。